Literature DB >> 22240463

HIV controllers are distinguished by chemokine expression profile and HIV-specific T-cell proliferative potential.

Catherine M Card1, Yoav Keynan, Julie Lajoie, Courtney P Bell, Magdy Dawood, Marissa Becker, Ken Kasper, Keith R Fowke.   

Abstract

BACKGROUND: HIV controllers demonstrate a natural ability to control HIV replication in the absence of antiretroviral therapy. We performed a comprehensive evaluation of inflammation and T-cell activation in a demographically unique cohort of HIV controllers and noncontrollers.
METHODS: Plasma concentrations of 22 cytokines and chemokines were evaluated using a multiplex bead array approach. Multicolor flow cytometry was used to measure baseline levels of T-cell activation and regulatory T cells (Tregs) and HIV-specific T-cell cytokine (interferon γ, interleukin 2) and proliferation responses.
RESULTS: HIV controllers were characterized by elevated macrophage inflammatory protein 1α and low levels of interferon γ-induced protein 10, monocyte chemotactic protein 1, and Transforming growth factor beta. Activated (CD38(+) HLA DR(+)) CD4(+) and CD8(+) T cells were reduced in HIV controllers relative to noncontrollers. HIV controllers and noncontrollers had comparable proportions of Tregs within the CD4(+) T-cell compartment, but absolute Treg counts were depleted in noncontrollers. Absolute Treg counts correlated inversely with T-cell activation. Proliferative CD4(+) and CD8(+) T-cell responses directed against HIV gag epitopes were found most frequently among HIV controllers with the lowest viral loads (elite controllers) and were rarely detected among noncontrollers, supporting a relationship between HIV-specific T-cell proliferation and viral control.
CONCLUSIONS: Collectively, these data suggest a model in which HIV controllers maintain low levels of viral replication through robust HIV-specific T-cell responses in an environment of low inflammation and reduced availability of activated target cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22240463     DOI: 10.1097/QAI.0b013e3182454fcd

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  17 in total

1.  Regulatory T-Cell Activity But Not Conventional HIV-Specific T-Cell Responses Are Associated With Protection From HIV-1 Infection.

Authors:  Laura Pattacini; Jared M Baeten; Katherine K Thomas; Tayler R Fluharty; Pamela M Murnane; Deborah Donnell; Elizabeth Bukusi; Allan Ronald; Nelly Mugo; Jairam R Lingappa; Connie Celum; M Juliana McElrath; Jennifer M Lund
Journal:  J Acquir Immune Defic Syndr       Date:  2016-06-01       Impact factor: 3.731

2.  Intestinal CD4 Depletion in HIV / SIV Infection.

Authors:  Ronald S Veazey
Journal:  Curr Immunol Rev       Date:  2019

3.  High eomesodermin expression among CD57+ CD8+ T cells identifies a CD8+ T cell subset associated with viral control during chronic human immunodeficiency virus infection.

Authors:  Federico Simonetta; Stéphane Hua; Camille Lécuroux; Sandie Gérard; Faroudy Boufassa; Asier Sáez-Cirión; Gianfranco Pancino; Cécile Goujard; Olivier Lambotte; Alain Venet; Christine Bourgeois
Journal:  J Virol       Date:  2014-08-06       Impact factor: 5.103

4.  Cytomegalovirus-specific responses of CD38⁺ memory T cells are skewed towards IFN-γ and dissociated from CD154 in HIV-1 infection.

Authors:  Gustavo Olvera-García; Enrique Espinosa; Scott F Sieg; Michael M Lederman
Journal:  AIDS       Date:  2014-01-28       Impact factor: 4.177

5.  The interplay between the X-DING-CD4, IFN-α and IL-8 gene activity in quiescent and mitogen- or HIV-1-exposed PBMCs from HIV-1 elite controllers, AIDS progressors and HIV-negative controls.

Authors:  Rakhee Sachdeva; Rasheda Y Shilpi; Malgorzata Simm
Journal:  Innate Immun       Date:  2013-06-10       Impact factor: 2.680

Review 6.  Functional Mechanisms of Treg in the Context of HIV Infection and the Janus Face of Immune Suppression.

Authors:  Jacobo López-Abente; Rafael Correa-Rocha; Marjorie Pion
Journal:  Front Immunol       Date:  2016-05-19       Impact factor: 7.561

7.  Nanotechnology as a New Therapeutic Approach to Prevent the HIV-Infection of Treg Cells.

Authors:  Didiana Jaramillo-Ruiz; Francisco Javier De La Mata; Rafael Gómez; Rafael Correa-Rocha; M Ángeles Muñoz-Fernández
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

8.  Cell-Mediated Immunity in Elite Controllers Naturally Controlling HIV Viral Load.

Authors:  Luca Genovese; Manuela Nebuloni; Massimo Alfano
Journal:  Front Immunol       Date:  2013-04-09       Impact factor: 7.561

9.  Activation associated ERK1/2 signaling impairments in CD8+ T cells co-localize with blunted polyclonal and HIV-1 specific effector functions in early untreated HIV-1 infection.

Authors:  Timothy Q Crawford; Fredrick M Hecht; Christopher D Pilcher; Lishomwa C Ndhlovu; Jason D Barbour
Journal:  PLoS One       Date:  2013-10-15       Impact factor: 3.240

Review 10.  Multifaceted Impact of Host C-C Chemokine CCL2 in the Immuno-Pathogenesis of HIV-1/M. tuberculosis Co-Infection.

Authors:  A Wahid Ansari; Adeeba Kamarulzaman; Reinhold E Schmidt
Journal:  Front Immunol       Date:  2013-10-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.